Shaila Kay Coffey, MD | |
987400 Nebraska Medical Center, Omaha, NE 68198-7400 | |
(402) 559-6637 | |
Not Available |
Full Name | Shaila Kay Coffey |
---|---|
Gender | Female |
Speciality | Emergency Medicine |
Experience | 8 Years |
Location | 987400 Nebraska Medical Center, Omaha, Nebraska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568811131 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | MD-45897 (Iowa) | Secondary |
207P00000X | Emergency Medicine | 7651 (Nebraska) | Secondary |
207P00000X | Emergency Medicine | 30759 (Nebraska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
The Nebraska Medical Center | Omaha, NE | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Unmc Physicians | 6002728391 | 1320 |
News Archive
Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.
NCD released its latest report on housing entitled The State of Housing in America in the 21st Century: A Disability Perspective, which provides recommendations to improve housing opportunities for people with disabilities.
Danielle Jones sits at her dining room table, studying the recipe for Nerd Lyfe (v2) vape juice. The supplies she's ordered online are arrayed before her: a plastic jug of unflavored liquid nicotine, a baking scale and bottles of artificial flavors that, combined, promise to re-create the fruity taste of Nerds Rope candy in vapor form.
Clovis Oncology today announced results from an ongoing Phase 1/2a monotherapy study evaluating lucitanib, the Company's novel, potent inhibitor of the tyrosine kinase activity of fibroblast growth factor receptors 1 through 3 (FGFR1-3), vascular endothelial growth factor receptors 1 through 3 (VEGFR1-3) and platelet-derived growth factor receptors alpha and beta (PDGFRα-β).
› Verified 3 days ago
Entity Name | Unmc Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417912114 PECOS PAC ID: 6002728391 Enrollment ID: O20031104000664 |
News Archive
Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.
NCD released its latest report on housing entitled The State of Housing in America in the 21st Century: A Disability Perspective, which provides recommendations to improve housing opportunities for people with disabilities.
Danielle Jones sits at her dining room table, studying the recipe for Nerd Lyfe (v2) vape juice. The supplies she's ordered online are arrayed before her: a plastic jug of unflavored liquid nicotine, a baking scale and bottles of artificial flavors that, combined, promise to re-create the fruity taste of Nerds Rope candy in vapor form.
Clovis Oncology today announced results from an ongoing Phase 1/2a monotherapy study evaluating lucitanib, the Company's novel, potent inhibitor of the tyrosine kinase activity of fibroblast growth factor receptors 1 through 3 (FGFR1-3), vascular endothelial growth factor receptors 1 through 3 (VEGFR1-3) and platelet-derived growth factor receptors alpha and beta (PDGFRα-β).
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Shaila Kay Coffey, MD 988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 Ph: () - | Shaila Kay Coffey, MD 987400 Nebraska Medical Center, Omaha, NE 68198-7400 Ph: (402) 559-6637 |
News Archive
Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.
NCD released its latest report on housing entitled The State of Housing in America in the 21st Century: A Disability Perspective, which provides recommendations to improve housing opportunities for people with disabilities.
Danielle Jones sits at her dining room table, studying the recipe for Nerd Lyfe (v2) vape juice. The supplies she's ordered online are arrayed before her: a plastic jug of unflavored liquid nicotine, a baking scale and bottles of artificial flavors that, combined, promise to re-create the fruity taste of Nerds Rope candy in vapor form.
Clovis Oncology today announced results from an ongoing Phase 1/2a monotherapy study evaluating lucitanib, the Company's novel, potent inhibitor of the tyrosine kinase activity of fibroblast growth factor receptors 1 through 3 (FGFR1-3), vascular endothelial growth factor receptors 1 through 3 (VEGFR1-3) and platelet-derived growth factor receptors alpha and beta (PDGFRα-β).
› Verified 3 days ago
Tyler Christian Pedersen, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 981150 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6802 | |
Chad E Branecki, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 988095 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-9800 Fax: 402-559-9840 | |
Dr. Robert S. Devin, M.D. Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 6901 N 72nd St, Omaha, NE 68122 Phone: 402-572-2225 Fax: 402-572-4974 | |
Dr. Kevin Michael Montgomery, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 981150 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6802 | |
Ryan Jorgenson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 981150 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6802 | |
Phillip Marshall Stratton, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4424 Fax: 402-354-4435 | |
Dr. James E Quinn, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4424 Fax: 402-354-4435 |